The Domino Effects of Microfinance and Chameleon Loan Groups—Loan‐Group Heterogeneity and Adaptability
Journal of International Development · 10.11.2026
DOI: 10.1002/jid.70126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of International Development, online erschienen am 10.11.2026. Verfasst von Megumi Nishimura und 1 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
This study examines why users participating in the same microcredit program experience different development outcomes. Using survey data from 147 farm households in India, we employ generalized structural equation modelling to distinguish the common effects of program participation from loan‐group–specific effects. Participation alone has limited effects and generates no domino effects between household income and women's empowerment. In contrast, heterogeneity in loan‐group characteristics explains why identical microfinance programs produce different outcomes by generating sequential relationships between income and selected dimensions of empowerment. The findings identify loan‐group adaptability as a key organisational mechanism through which microfinance achieves multiple development objectives.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Nishimura, M., & Joshi, A. (2026). The Domino Effects of Microfinance and Chameleon Loan Groups—Loan‐Group Heterogeneity and Adaptability. Journal of International Development. https://doi.org/10.1002/jid.70126
Vancouver
Nishimura M, Joshi A. The Domino Effects of Microfinance and Chameleon Loan Groups—Loan‐Group Heterogeneity and Adaptability. Journal of International Development. 2026. doi:10.1002/jid.70126
BibTeX
@article{Nishimura2026,
author = {Nishimura, Megumi and Joshi, Abhay},
title = {The Domino Effects of Microfinance and Chameleon Loan Groups—Loan‐Group Heterogeneity and Adaptability},
journal = {Journal of International Development},
year = {2026},
doi = {10.1002/jid.70126}
}
EUVIMED